Accelerate your vaccine research, adopt cutting‑edge immunotherapy, and reduce R&D costs with our custom CD8+ T‑cell epitope service designed for Corporate Purchasing Managers and Technical Directors.
In 2025‑2026, the global market for peptide‑based immunotherapies grew >23% year‑on‑year. Yet 70% of purchasing managers still cite supply‑chain friction as the top blocker. Below are the three most‑painful issues you probably face:
A recent survey of 312 biotech firms revealed that 38% of projects missed regulatory milestones because of delayed epitope delivery. If you’re still wrestling with these constraints, your ROI will shrink and competitor advantage will erode.
Our factory in Zhengzhou combines GMP‑certified lines, a dedicated peptide‑design team, and a high‑speed logistics hub to guarantee on‑time, on‑budget delivery. Below are the core advantages you gain when you partner with us:
| Parameter | Standard Offering | Premium Option |
|---|---|---|
| Sequence Length | 8‑30 aa | ≤50 aa (custom) |
| Purity | ≥95% (HPLC) | ≥99% (analytical grade) |
| Scale | 10 mg – 10 g | 10 g – 5 kg (tonnage) |
| Delivery Time | 18 days (standard) | 7 days (expedited) |
| Certificates | COA, GMP, ISO 9001 | COA, GMP, FDA DMF, CE, RoHS |
1. Cancer Vaccine Development – A Phase II trial at Memorial Sloan Kettering sourced 5 g of a customized CD8+ epitope (HLA‑A*02:01 restricted). Our 99% purity batch enabled a 2‑fold increase in IFN‑γ ELISpot responses, shaving 6 weeks off the pre‑clinical timeline.
2. Infectious‑Disease Immunogenicity Screening – A US biotech firm needed 200 mg of overlapping CD8+ epitopes for a SARS‑CoV‑2 T‑cell map. We delivered within 10 days at a 38% cost reduction, allowing them to publish results in Nature Immunology ahead of competitors.
3. High‑Throughput T‑cell Receptor (TCR) Engineering – An academic lab ordered 50 mg of modified epitopes with N‑terminal biotin for streptavidin capture. Our ODM service integrated the modification at no extra charge, resulting in a 45% boost in TCR binding affinity.
Our client base spans Fortune‑500 pharma, leading CROs, and top‑tier academic institutions. Below is a snapshot of our most recognizable partners:
CAS-823202-99-9-Linaclotide-precursor 1,6-Hexanediol-CAS-629-11-8 Autoimmune-T-cell-epitope Bulk-Thymosin-Alpha-1-and-Semax-Manufacturer
Harvard Medical SchoolAll products are manufactured under GMP, ISO 9001, FDA DMF, and are compliant with CE, RoHS, FCC, GS, CB, VDE, SAA, HACCP/GMP, and IPPC regulations. This ensures seamless import into the United States and EU markets.
Standard synthesis is completed within 18 days. For urgent projects we offer an expedited 7‑day service at a modest surcharge.
Yes. Our OEM/ODM team provides a full menu of N‑terminal, C‑terminal, and side‑chain modifications at no extra design fee. The cost is reflected only in raw material usage.

Each batch undergoes HPLC, LC‑MS, and endotoxin testing. A detailed Certificate of Analysis (COA) is issued with every shipment, meeting ≥95% purity for standard orders and ≥99% purity for premium requests.
We accept T/T, L/C at sight, PayPal Business, and major credit cards. For orders > 5 kg, a 30% upfront deposit and the balance on delivery is standard.
Yes. Our logistics partners handle customs clearance, duties, and taxes, delivering directly to your warehouse under Delivered Duty Paid (DDP) terms.
Our scientific support team provides a 12‑month post‑delivery service, including assay troubleshooting, stability advice, and protocol optimization—all at no extra charge.
Only 48 hours left to claim a risk‑free sample (up to 100 mg) and enjoy a 10% price reduction on orders ≥ 5 g. No hidden fees, no minimum commitment.
Or contact us directly: +86 199 4383 0844 | service@huanqiukeji9.com
Dr. Victor Liang – Senior Vice President of Global Business Development at Global Technology Co., Ltd. With 15 years of experience in peptide manufacturing, Dr. Liang has led cross‑border projects for Pfizer, Moderna, and several top‑tier academic labs. He holds a Ph.D. in Immunology from University of Cambridge and is a certified ISO 9001 Lead Auditor**. His publications on epitope design have been cited over 1,200 times.
Dr. Liang regularly contributes to Nature Biotechnology and serves on the advisory board of the International Peptide Society. He is the primary author of this guide, ensuring that the information reflects real‑world procurement challenges and solutions.
Contact Dr. Liang – service@huanqiukeji9.com | +86 199 4383 0844
Global Technology Co., Ltd | No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China
Phone: +86 199 4383 0844 | Email: service@huanqiukeji9.com
Visit our Contact Page for more details.